Understanding Duchenne muscular dystrophy-associated brain pathology
Disease Models & Mechanisms · 01.07.2025 · 18 (7)
DOI: 10.1242/dmm.052302 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Disease Models & Mechanisms, online erschienen am 01.08.2025. Verfasst von Minou A T Verhaeg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme.
Abstract (Originalsprache)
The most common neuromuscular disorder, Duchenne muscular dystrophy (DMD), is caused by mutations in the DMD gene, resulting in a lack of dystrophin. In addition to severe and progressive muscle wasting, a subset of individuals with DMD experience, to largely varying extents, behavioural and cognitive deficits, including a lower IQ, and neurological comorbidities, such as autism spectrum disorder, obsessive compulsive disorder and attention deficit hyperactivity disorder. Neuroimaging studies in individuals with DMD have identified widespread pathology, including structural, physiological and connective alterations. DMD mouse models exhibit a number of DMD-associated behavioural traits, including anxiety, social deficits and learning disabilities, and have been used to investigate DMD brain pathology. Although there are currently no therapies to treat DMD brain pathology, genetic approaches are being developed to restore dystrophin expression. In particular, the exon skipping approach shows promise in ameliorating certain DMD-associated behavioural deficits in preclinical settings. However, the therapeutic potential of postnatal restoration of dystrophin isoforms involved in neurodevelopment is unknown. Furthermore, challenges such as low dystrophin restoration efficacy and translatability from DMD mouse models to the clinic remain to be addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
- C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
ORCID-Profile: Minou A T Verhaeg, Maaike van Putten
Förderung
- Horizon 2020 Framework Programme
Zitieren
APA
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025). Understanding Duchenne muscular dystrophy-associated brain pathology. Disease Models & Mechanisms, 18(7). https://doi.org/10.1242/dmm.052302
Vancouver
Verhaeg MAT, Govaarts R, van Putten M. Understanding Duchenne muscular dystrophy-associated brain pathology. Disease Models & Mechanisms. 2025;18(7). doi:10.1242/dmm.052302
BibTeX
@article{Verhaeg2025,
author = {Verhaeg, Minou A T and Govaarts, Rosanne and van Putten, Maaike},
title = {Understanding Duchenne muscular dystrophy-associated brain pathology},
journal = {Disease Models & Mechanisms},
year = {2025},
volume = {18},
number = {7},
doi = {10.1242/dmm.052302}
}
EUVIMED